Jung Choi
CIK 1650126 · See Remarks · last filed 2025-12-03
Jung Choi is a corporate insider who has filed 48 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing shows the insider bought $138.3K of ANNX on Dec 3, 2025. Across all open-market trades the lifetime net is −$249.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $155.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$155.4K
2
48
-$249.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANNX | Director | 33,000 | $4.71 | $155.4K | $138.3K | 6 | 2025-12-03 |
| Global Blood Therapeutics, Inc. (GBT) Delisted | See Remarks | 0 | $68.49 | $0 | -$387.9K | 42 | 2022-10-06 |
Recent Filings
48 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-03 | ANNX | Buy (P) | +33,000 | $138.3K | EDGAR |
| 2025-06-09 | ANNX | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | ANNX | Grant (A) | — | $0 | EDGAR |
| 2023-06-12 | ANNX | Grant (A) | — | $0 | EDGAR |
| 2022-10-06 | Global Blood Therapeutics, Inc. (GBT) Delisted | Disp (D) | −251,672 | $0 | EDGAR |
| 2022-09-29 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | +25,634 | $700.0K | EDGAR |
| 2022-09-06 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | +3,110 | -$126.8K | EDGAR |
| 2022-08-03 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | +4,019 | -$68.9K | EDGAR |
| 2022-06-13 | ANNX | Grant (A) | — | $0 | EDGAR |
| 2022-03-03 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | +1,807 | -$28.6K | EDGAR |